Biosynthesis of a parkinsonism-preventing substance, 1-methyl-1,2,3,4- tetrahydroisoquinoline, is inhibited by parkinsonism-inducing compounds in rat brain mitochondrial fraction

Neuroscience Letters

Volumn 259, Issue 3, 1999, Pages 157-160

  Yamakawa, Takahiro ^a   Ohta, Shigeru ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Carboline; 1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; 1 methyl 4 phenylpyridinium; 1MeTIQ synthesizing enzyme; Haloperidol; Inhibition; Parkinsonism

Indexed keywords

1 METHYL 1,2,3,4 TETRAHYDROISOQUINOLINE DERIVATIVE; 1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BETA CARBOLINE; HALOPERIDOL; TETRAHYDROISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN MITOCHONDRION; CHEMICAL INTERACTION; MALE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; ANTIPSYCHOTIC AGENTS; BIOGENIC AMINES; HALOPERIDOL; HARMINE; ISOQUINOLINES; MALE; MITOCHONDRIA; NEUROTOXINS; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; TETRAHYDROISOQUINOLINES;

EID: 0033556435     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00913-6     Document Type: Article

References (17)

1. Collins M.A., Neafsey E.J., Matsubara K., Cobuzzi R.J. Jr., Rollema H. Indole-N-methylated β-carbolinium ions as potential brain-bioactivated neurotoxins. Brain Res. 570:1992;154-160.
2. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B.H. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:1994;793-807.
3. Kawai H., Makino Y., Hirobe M., Ohta S. Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism. J. Neurochem. 70:1998;745-751.
4. Kikuchi K., Nagatsu Y., Makino Y., Mashino T., Ohta S., Hirobe M. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds 1,2,3,4-tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline. Drug Metab. Dispos. 19:1991;257-262.
5. Kohno M., Ohta S., Hirobe M. Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain. Biochem. Biophys. Res. Commun. 140:1986;448-454.
6. Kotake Y., Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J. Neurochem. 65:1995;2633-2638.
7. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
8. Makino Y., Tasaki Y., Ohta S., Hirobe M. Confirmation of the enantiomers of 1-methyl-1,2,3,4-tetrahydroisoquinoline in the mouse brain and foods applying gas chromatography/mass spectrometry with negative ion chemical ionization. Biomed. Environ. Mass Specrom. 19:1990;415-419.
9. Matsubara K., Gonda T., Sawada H., Uezono T., Kobayashi Y., Kawamura T., Ohtaki K., Kimura K., Akaike A. Endogenous occurring β-carboline induces parkinsonism in non-primate animals: a possible causative protoxin in idiopathic Parkinson's disease. J. Neurochem. 70:1998;727-735.
10. Matsubara K., Senda T., Uezono T., Fukushima S., Ohta S., Igarashi K., Naoi M., Yamashita Y., Ohtaki K., Hayase N., Akutsu S., Kimura K. Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter. Eur. J. Pharmacol. 348:1998;77-84.
11. Mizuno Y., Sone N., Saitoh T. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain. J. Neurochem. 48:1987;1787-1793.
12. Nagatsu T. Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci. Res. 29:1997;99-111.
13. Ohta S., Kohno M., Makino Y., Tachikawa O., Hirobe M. Tetrahydroisoquinoline and 1-methyltetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease. Biomed. Res. 8:1987;453-456.
14. +-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies. J. Pharmacol. Exp. Ther. 268:1994;380-387.
15. Tasaki Y., Makino Y., Ohta S., Hirobe M. 1-Methyltetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities. J. Neurochem. 57:1991;1940-1943.
16. Tipton K.F., Singer T.P. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61:1993;1191-1206.
17. Yamakawa T., Ohta S. Isolation of 1-methyl-1,2,3,4-tetrahydroisoquinoline-synthesizing enzyme from rat brain: a possible Parkinson's disease-preventing enzyme. Biochem. Biophys. Res. Commun. 236:1997;676-681.